🎉Winners alert!! 🎉 Two deserving, early-stage life science start-ups were each awarded a Golden Ticket by Bristol Myers Squibb last night: Tinos Therapeutics and ALSMA Therapeutics! Held at Bristol Myers Squibb, the evening was an exciting celebration of cutting-edge science with connections forged between members of the ecosystem. The LabCentral Golden Ticket program exists to remove barriers for the most promising early-stage life sciences startups, giving them the space, resources, and community they need to turn bold science into real therapies. Congratulations to Tinos and ALSMA on their wins, and a thank you to all the founders who pitched! Thank you to all who attended to make this event so great, and a special thank you to Bristol Myers Squibb for their continued partnership and support!
-
-
-
-
-
+15
